Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bellobuono

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Digestive Diseases and Sciences|December 1, 1996
Interferon-ribavirin combination therapy for chronic hepatitis CS W Schalm, J T Brouwer, L Chemello, et al.
Transfusion|May 1, 1991
Prospective evaluation of posttransfusion hepatitisG Sirchia, A M Giovanetti, A Parravicini, et al.
Journal of Hepatology|June 1, 1995
Molecular epidemiology of hepatitis C virus infection among intravenous drug usersE Silini, F Bono, A Cividini, et al.
Vox Sanguinis|January 1, 1990
Prevalence of hepatitis C virus antibodies in Italian blood donors. The Italian Cooperative GroupG Sirchia, D Almini, A Bellobuono, et al.
Minerva Medica|May 2, 1975
[Double-blind polycentric study of the action of S-adenosylmethionine in hepatic cirrhosis]G Labo, F Miglio, A D'Ambro, et al.
Journal of Hepatology|May 1, 1997
Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C. Meta-analysis of individual patient data from European centersS W Schalm, B E Hansen, L Chemello, et al.
Gut|September 14, 2004
Long term clinical outcome of chronic hepatitis C patients with sustained virological response to interferon monotherapyB J Veldt, G Saracco, N Boyer, et al.
Gastroenterology|July 27, 1999
Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: analysis of individual patient data of six controlled trials. Eurohep Study Group for Viral HepatitisS W Schalm, O Weiland, B E Hansen, et al.
European Journal of Gastroenterology & Hepatology|November 24, 1999
Antioxidant drugs combined with alpha-interferon in chronic hepatitis C not responsive to alpha-interferon alone: a randomized, multicentre studyG Idéo, A Bellobuono, S Tempini, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Digestive Diseases and Sciences|December 1, 1996
Interferon-ribavirin combination therapy for chronic hepatitis CS W Schalm, J T Brouwer, L Chemello, et al.
Transfusion|May 1, 1991
Prospective evaluation of posttransfusion hepatitisG Sirchia, A M Giovanetti, A Parravicini, et al.
Journal of Hepatology|June 1, 1995
Molecular epidemiology of hepatitis C virus infection among intravenous drug usersE Silini, F Bono, A Cividini, et al.
Vox Sanguinis|January 1, 1990
Prevalence of hepatitis C virus antibodies in Italian blood donors. The Italian Cooperative GroupG Sirchia, D Almini, A Bellobuono, et al.
Minerva Medica|May 2, 1975
[Double-blind polycentric study of the action of S-adenosylmethionine in hepatic cirrhosis]G Labo, F Miglio, A D'Ambro, et al.
Journal of Hepatology|May 1, 1997
Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C. Meta-analysis of individual patient data from European centersS W Schalm, B E Hansen, L Chemello, et al.
Gut|September 14, 2004
Long term clinical outcome of chronic hepatitis C patients with sustained virological response to interferon monotherapyB J Veldt, G Saracco, N Boyer, et al.
Gastroenterology|July 27, 1999
Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: analysis of individual patient data of six controlled trials. Eurohep Study Group for Viral HepatitisS W Schalm, O Weiland, B E Hansen, et al.
European Journal of Gastroenterology & Hepatology|November 24, 1999
Antioxidant drugs combined with alpha-interferon in chronic hepatitis C not responsive to alpha-interferon alone: a randomized, multicentre studyG Idéo, A Bellobuono, S Tempini, et al.
Pageof 2